Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis

Pediatric Infectious Disease Journal

Volumn 33, Issue 6, 2014, Pages 566-570

  Olariu, Tudor R ^a,b,c   Remington, Jack S ^a,b   Montoya, Jose G ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

cerebrospinal fluid; Congenital toxoplasmosis; polymerase chain reaction; Toxoplasma gondii; toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ARTICLE; BRAIN CALCIFICATION; CEREBROSPINAL FLUID ANALYSIS; CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC PROCEDURE; EYE DISEASE; HUMAN; HYDROCEPHALUS; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; BLOOD; CEREBROSPINAL FLUID; FEMALE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARASITOLOGY; PREGNANCY; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 84901498947     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000256     Document Type: Article

References (38)

1. R emington JS McLeod R Thuilliez P Desmonts G. Toxoplasmosis. In: Remington JS Klein JO Wilson CB et al. Infectious Diseases of the Fetus and Newborn Infant. 7th ed. Philadelphia: Elsevier Saunders; 2011.
2. Boyer KM Holfels E Roizen N et al.; Toxoplasmosis Study Group. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenata l management and screening. Am J Obstet Gynecol. 2005;192:564-571. (Pubitemid 40214997)
3. McLeod R Boyer K Karrison T et al. Outcome of treatment for congenital toxoplasmosis 1981-2004: the National Collaborative Chicago-Based Congenital Toxoplasmosis Study. Clin Infect Dis. 2006; 42: 1383-1394.
4. McLeod R Kieffer F Sautter M et al. Why prevent diagnose and treat congenital toxoplasmosis Mem Inst Oswaldo Cruz. 2009;104:320-344.
5. McLeod R Boyer KM Lee D et al. Prematurity and severity are associated with Toxoplasma gondii Alleles (NCCCTS 1981-2009). Clin Infect Dis. 2012;54:1595-605.
6. Wallon M Dunn D Slimani D et al. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA Eur J Pediatr. 1999;158:645-649. (Pubitemid 29331033)
7. N aessens A Jenum PA Pollak A et al. Diagnosis of congenital toxoplasmosis in the neonatal period. A multicenter evaluation. J Infect Dis. 1999;181:2018-2022.
8. Bessières MH Berrebi A Rolland M et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol. 2001;94:37-45. (Pubitemid 32007997)
9. Bessiè res MH Berrebi A Cassaing S et al. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of conge nital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009;104:389-392.
10. Olariu TR Remington JS McLeod R et al. Severe congenital toxoplasmosis in the United States: clinical and serologic findings i n untreated infants. Pediatr Infect Dis J. 2011;30:1056-1061.
11. G ross U Müller J Roos T et al. Possible reasons for failure of conventional tests for diagnosis of fatal congenital toxoplasmosis: report of a case diagnosed by PCR and immunoblot. Infection. 1992;20:149-152.
12. van de Ven E Melchers W Galama J Camps W Meuwissen J. Identification of Toxoplasma gondii infections by BI gene amplifi cation. J Clin Microbiol. 1991; 19: 2120-2124.
13. McAuley J Boyer KM Patel D et al. Early and longitudinal evaluations of treated infants and children a nd untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994;18:38-72. (Pubitemid 24025917)
14. Sabin AB Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science. 1948;108:660-663.
15. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(suppl 1):S73-S82. (Pubitemid 34142832)
16. G rover CM Thulliez P Remington JS et al. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol. 1990;28:2297-2301. (Pubitemid 20299125)
17. Hohlfeld P Daffos F Costa JM et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994;331:69 5-699.
18. R omand S Wallon M Franck J et al. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 2001;97:296-300. (Pubitemid 32126349)
19. Wallon M Franck J Thulliez P et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol. 2010;115:727-733.
20. Bergström T Ricksten A Nen onen N et al. Congenital Toxoplasma gondii infection diagnosed by PCR amplification of peripheral mononuclear blood cells from a child and mother. Scand J Infect Dis. 1998;30:202-204. (Pubitemid 28389087)
21. Fuentes I Rodriguez M Domingo CJ et al. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol. 1996;34:2368-2371. (Pubitemid 26307773)
22. G ross U Roggenkamp A Janitschke K et al. Improved sensi tivity of the polymerase chain reaction for detection of Toxoplasma gondii in biological and human clinical specimens. Eur J Clin Microbiol Infect Dis. 1992;11:33-39
23. Said RN Zaki MM Abdelrazik MB. Congenital toxopla smosis: evaluation of molecular and serological methods for achieving economic and early diagnosis among Egyptian preterm infants. J Trop Pediatr. 2011;57:333-339.
24. Sterkers Y Ribot J Albaba S et al. Diagnosis of congenital toxoplasmosis by polymerase chain reaction on neonatal peripheral blood. Diagn Microbiol Infect Dis. 2011;71:174-176.
25. T orres E Rivera R Cardona N et al. Evaluation of IgG anti-toxoplasma avidity and PCR in the postnatal diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2013;32:693-695.
26. Fricker-Hidalgo H Brenier-Pinchart MP Schaal JP et al. Value of Toxopl asma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2007;26: 845-846. (Pubitemid 47329860)
27. Fricker-Hidalgo H Pelloux H Racinet C et al. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction in vivo and in vitro cultures. Placenta. 1998;19:545-549. (Pubitemid 28430009)
28. Sterkers Y Pratlong F Albaba S et al. Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection. J Clin Microbiol. 2012;50:3944-3951.
29. Sterkers Y Varlet-Marie E Marty P et al.; ANOFEL Toxoplasma-PCR Quality Control Group. Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year survey. Clin Microbiol Infect. 2010;16:1594-1602.
30. Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg. 2002;96(suppl 1):S205-S215.
31. Ferguson DJ Bowker C Jeffery KJ et al. Congenital toxoplasmosis: continued parasite proliferation in the fetal brain despite maternal immunological control in other tissues. Clin Infect Dis. 2013;56:204-208.
32. Wolf A Cowen D. Granulomatous encephalomyelitis due to an encephalitozoon (encephalitozoic encephalomyelitis): a new protozoan disease of man. Bull Neurol Inst NY. 1937; 6: 306-71.
33. Jamieson SE de Roubaix LA Cortina-Borja M et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One. 2008;3:e2285.
34. A jzenberg D CognéN Paris L et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis and correlation with clinical findings. J Infect Dis. 2002;186:684-689. (Pubitemid 34925541)
35. E lbez-Rubinstein A Ajzenberg D DardéML et al. Congenital toxoplasmosis and reinfection during pregnancy: case report strain characterization experimental model of reinfection and review. J Infect Dis. 2009;199:280-285.
36. R omand S Chosson M Franck J et al. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol. 2004 190 797-802. (Pubitemid 38406796)
37. D unn D Wallon M Peyron F et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829-1833. (Pubitemid 29251014)
38. Cortina-Borja M Tan HK Wallon M et al.; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010;7: pii:e1000351 .